DocGo (DCGO)
Nasdaq Market Open
DocGo Inc. is a healthcare services company focused on mobile medical care and medical transportation. Its common stock trades under the ticker DCGO. The company aims to bring clinical services closer to patients by using a care delivery platform that supports in-home treatment, on-site medical support, virtual care coordination, and ambulance operations.
DocGo’s business is organized around two main segments: Mobile Health Services and Transportation Services. Mobile Health Services is the larger revenue contributor and includes care delivered outside traditional hospitals or clinics, such as at patients’ homes, workplaces, shelters, community sites, and large events. These services can include basic medical assessments, testing, monitoring, and other healthcare support depending on customer contracts and local requirements.
The Transportation Services segment provides ambulance and medical mobility services, helping move patients safely between care settings or respond to medical needs in the community. This gives DocGo exposure to both emergency and non-emergency medical transport markets, while also complementing its broader mobile health model.
The company serves public agencies, healthcare systems, insurers, employers, event organizers, and other organizations that need flexible clinical capacity. Its operating footprint is concentrated in the United States, with additional revenue generated in the United Kingdom. This geographic mix reflects demand for alternatives to facility-based care and for outsourced healthcare logistics.
DocGo is distinctive because it combines field-based clinicians, technology-enabled dispatch and care management, and transportation capabilities. Its model is tied to healthcare trends such as decentralizing care, reducing unnecessary hospital visits, and meeting patients where they are. At the same time, its performance depends on contract execution, staffing, reimbursement dynamics, and regulatory requirements in the healthcare markets it serves.
Last updated
- Market Cap
- 56.3M
- P/E
- —
- P/FCF
- 3.39
- P/S
- 0.19
- Enterprise Value
- 38.24M
- Sector
- —
- Industry
- —
- Address
- 685 THIRD AVENUE, NEW YORK, NY, 10017
Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm
Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm
Investor Alert: Class Action Lawsuits Against General Motors, DocGo, Estée Lauder, and Axsome Therapeutics Survive Motions to Dismiss — Johnson Fistel, PLLP Encourages Shareholders to Contact the Firm
DocGo Inc. (DCGO) Matches Q1 Earnings Estimates
Earnings Preview: AMN Healthcare Services (AMN) Q1 Earnings Expected to Decline
DocGo Inc. (DCGO) Q4 Earnings Lag Estimates
DocGo Inc. (DCGO) Moves 6.8% Higher: Will This Strength Last?
DocGo Inc. (DCGO) Reports Q2 Loss, Tops Revenue Estimates
DocGo Inc. (DCGO) Surges 5.0%: Is This an Indication of Further Gains?
Are Options Traders Betting on a Big Move in DocGo (DCGO) Stock?
DocGo Inc. (DCGO) Reports Q1 Loss, Lags Revenue Estimates
DocGo Inc. (DCGO) Tops Q4 Earnings and Revenue Estimates
Is Motion Acquisition (DCGO) Outperforming Other Medical Stocks This Year?
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
Wall Street Analysts Think DocGo Inc. (DCGO) Could Surge 27%: Read This Before Placing a Bet
Can DocGo Inc. (DCGO) Climb 30% to Reach the Level Wall Street Analysts Expect?
Can DocGo Inc. (DCGO) Keep the Earnings Surprise Streak Alive?
Why Earnings Season Could Be Great for DocGo (DCGO)
3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1
Wall Street Analysts See a 92% Upside in DocGo Inc. (DCGO): Can the Stock Really Move This High?
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 56.3M
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 38.24M
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 0.43
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.19
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- -0.62
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.13
- EPS
- -1.9
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 2.13%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 3.39
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 2.8
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 16.63M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -141.91%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -89.74%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.13
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.79
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.79
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.46
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 605.12K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 0.57
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 75.55M | 74.94M | 70.81M | 80.42M | 96.03M |
| Gross profit | 23.88M | 24.36M | 18.13M | 25.42M | 30.85M |
| Operating income | -18.71M | -104.58M | -41.98M | -17.48M | -14M |
| EBITDA | -12.39M | -20.35M | -16.81M | -11.71M | -7.27M |
| Net income | -14.76M | -134.07M | -27.77M | -11.16M | -9.41M |
| Basic EPS | -0.15 | -1.35 | -0.28 | -0.11 | -0.09 |
| Diluted EPS | -0.15 | -1.35 | -0.28 | -0.11 | -0.09 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 209.23M | 217.1M | 353.78M | 408.26M | 430.79M |
| Total liabilities | 98.02M | 91.23M | 93.12M | 120.53M | 128.87M |
| Total equity | 111.21M | 125.87M | 260.66M | 287.73M | 301.92M |
| Cash & equivalents | 35.68M | 51.02M | 73.36M | 104.16M | 79.01M |
| Current assets | 138.17M | 152.4M | 190.23M | 236.57M | 262.53M |
| Current liabilities | 77.22M | 67.49M | 73.58M | 100.15M | 107.57M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -4.66M | -10.47M | 1.66M | 33.6M | 9.22M |
| Investing cash flow | 1.66M | -13.07M | 1.1M | -21.38M | -5.29M |
| Financing cash flow | -2.46M | -1.86M | -33.05M | -7.38M | -8.52M |
| Change in cash | -5.67M | -25.12M | -30.95M | 5.5M | -4.28M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — DocGo Inc. | View Filing | |
| form 4 | Form 4 — Bienstock Lee | View Filing | |
| edgar index | 10-Q — DocGo Inc. | View Filing | |
| edgar index | 8-K — DocGo Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — DocGo Inc. | View Filing | |
| edgar index | DEFA14A — DocGo Inc. | View Filing | |
| edgar index | ARS — DocGo Inc. | View Filing | |
| edgar index | 8-K — DocGo Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | PRE 14A — DocGo Inc. | View Filing | |
| edgar index | SCHEDULE 13G/A — DocGo Inc. | View Filing | |
| edgar index | S-8 — DocGo Inc. | View Filing | |
| edgar index | 10-K — DocGo Inc. | View Filing | |
| edgar index | 8-K — DocGo Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | SCHEDULE 13D/A — DocGo Inc. | View Filing | |
| edgar index | 8-K — DocGo Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 144 — DocGo Inc. | View Filing | |
| form 4 | Form 4 — Tendler Ely D | View Filing | |
| form 4 | Form 4 — ROSENBERG NORMAN | View Filing | |
| form 4 | Form 4 — Sugrue Stephen | View Filing | |
| form 4 | Form 4 — Bienstock Lee | View Filing | |
| edgar index | 8-K — DocGo Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — TRAVERS JAMES M | View Filing | |
| form 4 | Form 4 — TRAVERS JAMES M | View Filing | |
| form 4 | Form 4 — Burdiek Michael J | View Filing | |
| form 4 | Form 4 — Tendler Ely D | View Filing | |
| form 4 | Form 4 — ROSENBERG NORMAN | View Filing | |
| form 4 | Form 4 — Leite Etalvina | View Filing | |
| form 4 | Form 4 — Smedra Ira | View Filing | |
| form 4 | Form 4 — Sugrue Stephen | View Filing | |
| form 4 | Form 4 — Bienstock Lee | View Filing | |
| edgar index | 8-K — DocGo Inc. | View Filing | |
| edgar index | 10-Q — DocGo Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K/A — DocGo Inc. | View Filing | |
| edgar index | 8-K — DocGo Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| form 4 | Form 4 — Klasko Stephen K. M.D. | View Filing | |
| edgar index | 10-Q — DocGo Inc. | View Filing | |
| edgar index | 8-K — DocGo Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| form 4 | Form 4 — Bienstock Lee | View Filing | |
| form 4 | Form 4 — ROSENBERG NORMAN | View Filing | |
| form 4 | Form 4 — Sugrue Stephen | View Filing | |
| edgar index | 8-K — DocGo Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — DocGo Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| form 4 | Form 4 — Burdiek Michael J | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| form 4 | Form 4 — Burdiek Michael J | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing | |
| edgar index | 4 — DocGo Inc. | View Filing |